Insider · CIK 0001766524
Sheldon L. Koenig
ceopresidentofficerdirector
Files at ESPR (Esperion Therapeutics, Inc.). First filing Dec 18, 2024, latest Dec 18, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 5
$0 bought, $341k sold
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 52Moderate | Esperion Therapeutics, Inc. | $177k 48,244 shares | -3% | - | |
| 49Moderate | Esperion Therapeutics, Inc. | $79k 28,427 shares | -2% | - | |
| 46Moderate | Esperion Therapeutics, Inc. | $34k 30,474 shares | -2% | - | |
| 40Moderate | Esperion Therapeutics, Inc. | $20k 13,047 shares | -1% | - | |
| 45Moderate | Esperion Therapeutics, Inc. | $31k 12,447 shares | -2% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 17, 2025 | ESPR Esperion Therapeutics, Inc. | SOpen-market sale Common Stock | -48,244 | $3.67 | $177k | 1,470,587 | Dec 18, 2025 |
| Sep 17, 2025 | ESPR Esperion Therapeutics, Inc. | SOpen-market sale Common Stock | -28,427 | $2.79 | $79k | 1,518,831 | Sep 18, 2025 |
| Jun 17, 2025 | ESPR Esperion Therapeutics, Inc. | SOpen-market sale Common Stock | -30,474 | $1.11 | $34k | 1,541,488 | Jun 18, 2025 |
| Mar 18, 2025 | ESPR Esperion Therapeutics, Inc. | SOpen-market sale Common Stock | -13,047 | $1.50 | $20k | 1,571,962 | Mar 19, 2025 |
| Mar 14, 2025 | ESPR Esperion Therapeutics, Inc. | AGrant or award Common Stock | +840,000 | $0.00 | $0 | 1,585,009 | Mar 17, 2025 |
| Mar 14, 2025 | ESPR Esperion Therapeutics, Inc. | AGrant or award Stock Option (right to buyderivative | +753,000 | $0.00 | $0 | 753,000 | Mar 17, 2025 |
| Dec 17, 2024 | ESPR Esperion Therapeutics, Inc. | SOpen-market sale Common Stock | -12,447 | $2.47 | $31k | 739,819 | Dec 18, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.